Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Nov;107(11):1709-1715.
doi: 10.1136/bjo-2021-321005. Epub 2022 Sep 1.

Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS)

Affiliations
Randomized Controlled Trial

Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS)

Joe Rappon et al. Br J Ophthalmol. 2023 Nov.

Abstract

Background: Mutations in the L/M cone opsin gene array cause abnormally high perceived retinal contrast and the development of myopia. Environmental factors may also lead to high visual contrast and cause myopia. Diffusion optics technology (DOT) lenses are designed to reduce contrast signalling in the retina and slow myopia progression.

Methods: The Control of Myopia Using Peripheral Diffusion Lenses Efficacy and Safety Study (CYPRESS, NCT03623074) is a 36-month, multicentre, randomised, controlled, double-masked trial evaluating two investigational spectacle lenses versus control lenses in myopic children aged 6-10, with a planned interim analysis at 12 months. The primary endpoints are change from baseline in axial length (AL) and spherical equivalent refraction (SER).

Results: 256 children (58% female; mean age at screening, 8.1 years) were dispensed spectacles. Across all groups, baseline averages were AL 24.02 mm (SD±0.77 mm), SER -2.01 D (SD±0.9 D) using manifest refraction, and SER -1.94 D (SD±1.0 D) using cycloplegic autorefraction. At 12 months, mean difference in SER progression for test 1 versus control was -0.40 D (p<0.0001), representing a 74% reduction and -0.32 D for Test 2 (p<0.0001), representing a 59% reduction. The difference in AL progression for test 1 versus control was 0.15 mm (p<0.0001) and test 2 versus control was 0.10 mm (p=0.0018).

Conclusion: 12-month results from this ongoing trial demonstrate the safety and effectiveness of DOT spectacles for reducing myopic progression.

Keywords: Clinical Trial; Treatment other; Vision.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JR is former Chief Medical Officer at SightGlass Vision, and in this role has received meeting and/or travel support, participated in data safety monitoring/advisory boards, and owns stock in the company. CC reports consulting fees from SightGlass Vision and has a pending patent application (17/259,779). GY reports grants from Johnson & Johnson Vision, CooperVision, and Essilor. JN and MN report royalties/licenses, consulting fees and meeting and/or travel support from SightGlass Vision. JN and MN are cofounders and have stock ownership in SightGlass Vision, and are listed as Inventors on patents issued for DOT lens, owned by the University of Washington. TC reports consulting fees, meeting and/or travel support, patents and stock ownership in his role as employee, officer and board member for SightGlass Vision.

Figures

Figure 1
Figure 1
Contrast hypothesis of myopia and development of DOT lens. X-chromosome opsin gene array for a male with high myopia due to the LVAVA haplotype is shown. (A) OPN1LW gene (pink) with LVAVA exon 3 haplotype and OPN1MW gene (green) with MVVVA exon 3 haplotype. The LVAVA haplotype causes exon three to be skipped in pre-mRNA splicing so only about 6% of the mRNA is full length. (B) L (pink) and M (green) cones have dramatically different photopigment OD because of mis-splicing. S cones are blue. (C) Retina signals high contrast even under uniform white light because of OD differences. Activity of L cones (grey) is low, activity of M and S cones (black) is high. We hypothesised that the constitutive contrast signalling due to photopigment OD differences stimulates axial elongation of the eye and causes myopia. (D) The hypothesis led to the development of a novel spectacle lens (DOT lens) that reduces contrast (left lens) compared with a standard of care lens (right). DOT, diffusion optics technology; OD, optical density.
Figure 2
Figure 2
Least squares mean changes (±SE) from baseline for AL (A) and SER (B), mITT population. LS, SR and p values are derived from an ANCOVA model adjusting for age, gender, and baseline AL or SER value. Missing data were handled by the multiple imputation with regression method. The least squares mean changes (±SE) from baseline from the same model with data as observed (ie, no imputation) in AL or SER and was 0.15 (±0.020) mm or −0.14 (±0.052) D for test 1 and 0.19 (±0.023) mm or −0.24 (±0.061) D for test 2 vs 0.30 (±0.018) mm or −0.54 (±0.049) D for the control group. AL, axial length; ANCOVA, analysis of covariance; D, dioptre; LS, least squares; mITT, modified intention-to-treat; SER, spherical equivalent refraction.
Figure 3
Figure 3
Scatterplot of change from baseline in SER at 12 months versus change from baseline in AL for each treatment group. AL, axial length; D, dioptre; SER, spherical equivalent refraction.

Similar articles

Cited by

References

    1. Holden BA, Fricke TR, Wilson DA, et al. . Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016;123:1036–42. 10.1016/j.ophtha.2016.01.006 - DOI - PubMed
    1. Wu P-C, Chuang M-N, Choi J, et al. . Update in myopia and treatment strategy of atropine use in myopia control. Eye 2019;33:3–13. 10.1038/s41433-018-0139-7 - DOI - PMC - PubMed
    1. Pugazhendhi S, Ambati B, Hunter AA. Pathogenesis and prevention of worsening axial elongation in pathological myopia. Clin Ophthalmol 2020;14:853–73. 10.2147/OPTH.S241435 - DOI - PMC - PubMed
    1. Chiang W-Y, Chen Y-W, Liu Y-P, et al. . Early age of the first myopic spectacle prescription, as an indicator of early onset of myopia, is a risk factor for high myopia in adulthood. J Ophthalmol 2021;2021:1–9. 10.1155/2021/6612116 - DOI - PMC - PubMed
    1. Hu Y, Ding X, Guo X, et al. . Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese cohort. JAMA Ophthalmol 2020;138:1129–34. 10.1001/jamaophthalmol.2020.3451 - DOI - PMC - PubMed

Publication types

Associated data